Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
New England Journal of Medicine · 2026
DOI: 10.1056/nejmoa2607978 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift New England Journal of Medicine, 2026. Verfasst von Daehoon Kim und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Atrial Fibrillation, Factor Xa Inhibitors, Stroke. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Samjin Pharmaceutical Co., Ltd., Hanmi Pharmaceutical Co., Ltd., Ministry of Health & Welfare of the Republic of Korea.
Themen: Schlaganfall
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
- Division of Cardiology, Daegu Catholic University Hospital, Daegu, South Korea.
- Department of Cardiology, Korea University Hospital, Seoul, South Korea.
- Department of Cardiology, Ewha Womans University Hospital, Seoul, South Korea.
- Department of Cardiology, Hanyang University Seoul Hospital, Seoul, South Korea.
- Department of Cardiology, Seoul National University Bundang Hospital, Seongnam, South Korea.
ORCID-Profile: Eue-Keun Choi, Boyoung Joung
Förderung
- Samjin Pharmaceutical Co., Ltd.
- Hanmi Pharmaceutical Co., Ltd.
- Ministry of Health & Welfare of the Republic of Korea
Zitieren
APA
Kim, D., Lee, Y. S., Shim, J., Yu, H. T., Park, J., Park, J. K., Oh, I. Y., Kang, K. W., Choi, E. K., Park, K. M., Park, H. S., Kim, D. H., Park, H. W., Kim, J., Ko, J. S., Kim, D., Kim, J. Y., Kim, J. B., Sung, J. H., …, & SINGLE-AF Investigators (2026). Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2607978
Vancouver
Kim D, Lee YS, Shim J, Yu HT, Park J, Park JK, et al. Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk. New England Journal of Medicine. 2026. doi:10.1056/nejmoa2607978
BibTeX
@article{Kim2026,
author = {Kim, Daehoon and Lee, Young Soo and Shim, Jaemin and Yu, Hee Tae and Park, Junbeom and Park, Jin-Kyu and Oh, Il-Young and Kang, Ki-Woon and Choi, Eue-Keun and Park, Kyoung-Min and Park, Hyoung-Seob and Kim, Dae-Hyeok and Park, Hyung Wook and Kim, Jun and Ko, Jum-Suk and Kim, Dongmin and Kim, Jong-Youn and Kim, Jin-Bae and Sung, Jung-Hoon and Kim, Tae-Hoon and Uhm, Jae-Sun and Pak, Hui-Nam and Joung, Boyoung and SINGLE-AF Investigators, SINGLE-AF Investigators},
title = {Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk},
journal = {New England Journal of Medicine},
year = {2026},
doi = {10.1056/nejmoa2607978}
}
EUVIMED